Advanced Medical Optics (EYE)

If the proposed merger with Abbott is not completed, we may need to revisit our efforts to reduce debt and restructure our balance sheet.

Prior to the announcement of the merger, we were actively working to de-leverage our balance sheet. As a result of the proposed merger, we have not continued to pursue these strategies. If the merger is not completed, we may need to re-engage in these efforts. Also, if the merger is not completed, we may experience negative reactions from the financial markets, our stockholders, potential investors and bankers. As a result, strategies to reduce debt and restructure our balance sheet that were previously available to us may no longer be available, or if available, may not be available on favorable terms. Either of these outcomes could have a material adverse effect on our financial condition and liquidity.

If the proposed merger with Abbott is not completed, we may need to revisit our efforts to reduce debt and restructure our balance
sheet.

Prior to the announcement of the merger, we were actively working to de-leverage our balance sheet. As a result of the
proposed merger, we have not continued to pursue these strategies. If the merger is not completed, we may need to re-engage in these efforts. Also, if the merger is not completed, we may experience negative reactions from the financial markets, our
stockholders, potential investors and bankers. As a result, strategies to reduce debt and restructure our balance sheet that were previously available to us may no longer be available, or if available, may not be available on favorable terms. Either
of these outcomes could have a material adverse effect on our financial condition and liquidity.

If the proposed merger with Abbott is not completed, we may need to revisit our efforts to reduce debt and restructure our balance
sheet.

Prior to the announcement of the merger, we were actively working to de-leverage our balance sheet. As a result of the
proposed merger, we have not continued to pursue these strategies. If the merger is not completed, we may need to re-engage in these efforts. Also, if the merger is not completed, we may experience negative reactions from the financial markets, our
stockholders, potential investors and bankers. As a result, strategies to reduce debt and restructure our balance sheet that were previously available to us may no longer be available, or if available, may not be available on favorable terms. Either
of these outcomes could have a material adverse effect on our financial condition and liquidity.